“…In an additional series of experiments, the slices were preincubated with ACSF containing one of several compounds for 2 h before transferring slices to the recording chamber and perfusion with normal ACSF. The following reagents were used for in vitro experiments: the GABA A receptor agonists muscimol (1 M) (Akhondzadehet al, 2002) and zolpidem (0.3 M) (Liang et al, 2004) (Saghatelyan et a., 2003), the nicotinic acetylcholine receptor agonist nicotine (1 M) (Fujii et al, 2000), the NMDA receptor antagonist DL-2-amino-5-phosphonopentanoic acid (APV; 50 M) (Mockett et al, 2002), the antagonist of metabotropic glutamate receptors (RS)-␣-methyl-4-carboxyphenyglycine (MCPG; 200 M) (Breakwell et al, 1998), the blocker of L-type Ca 2ϩ channels nifedipine (1 M) (He et al, 2001), the inhibitor of protein serine/ threonine phosphatases types 1 and 2A (PP1/2A) calyculin A (1 M) (Huang et al, 2001), and the HNK-1 peptidomimetic or scrambled control peptide (100 g/ml) (Simon-Haldi et al, 2002;Saghatelyan et a., 2003). The use of peptidomimetic has advantages over the native carbohydrate because the peptide is more stable, and considerably more easily synthesized or isolated.…”